Unlocking ferroptosis in prostate cancer — the road to novel therapies and imaging markers
Article in Nature Reviews Urology (April 2024)
The most recent citing publications are shown below. View all 64 publications that cite this research output on Dimensions.
Loss of AR-regulated AFF3 contributes to prostate cancer progression and reduces ferroptosis sensitivity by downregulating ACSL4 based on single-cell sequencing analysis
Article in Apoptosis (March 2024)
177Lu-PSMA therapy in metastatic prostate cancer: An updated review of prognostic and predictive biomarkers
Article in Cancer Treatment Reviews (February 2024)